Surrozen, Inc./DE (SRZN) - Dilution Analysis

10-Q filing | 11.6M shares outstanding

S-3 filing: The filing is an S-3 registration statement for a potential offering of common stock with an aggregate offering price of up to $50,000,000 through an at-the-market offering.

10-Q filing | 8.6M shares outstanding

10-Q filing | 8.6M shares outstanding

S-3 filing: The company may offer and sell any combination of common stock, preferred stock, debt securities, or warrants, either individually or in combination, up to a total amount of $150,000,000.

10-Q filing | 8.6M shares outstanding

S-3 filing: This S-3 filing registers the resale of common stock, shares issuable upon exercise of pre-funded warrants, and shares issuable upon exercise of Series E common stock warrants by selling stockholders.

10-K filing | 3.3M shares outstanding

8-K filing: Surrozen, Inc. completed the first tranche of a private placement on March 26, 2025, issuing 5,213,415 shares, pre-funded warrants to purchase 1,373,000 shares, and warrants to purchase 3,293,207 shares at $11.60 per share unit and $11.5999 per pre-funded warrant unit for gross proceeds of approximately $76.4 million. ($152.8M proceeds)

10-Q filing | 3.2M shares outstanding

10-Q filing | 3.2M shares outstanding

10-Q filing | 3.2M shares outstanding

S-3 filing: This S-3 filing registers the resale of common stock, pre-funded warrants, Series A common stock warrants, Series B common stock warrants, Series C common stock warrants and Series D common stock warrants by selling stockholders.

10-K filing | 3.2M shares outstanding

8-K filing: Surrozen, Inc. entered into a Securities Purchase Agreement to issue and sell shares of common stock, pre-funded warrants, and warrants to institutional investors and management in a private placement for gross proceeds of approximately $17.5 million. ($17.03M proceeds)

8-K filing: Stock split 1-for-15 | Outstanding: 30,497,000 → 2,033,133

10-Q filing | 30.5M shares outstanding

10-Q filing | 30.1M shares outstanding

10-Q filing | 30.1M shares outstanding

10-K filing | 30.1M shares outstanding

POS AM filing: This is a POS AM filing for up to 31,612,348 shares of common stock (including shares issuable upon exercise of warrants) and up to 4,151,323 warrants to purchase common stock.

POS AM filing: This POS AM filing registers for resale 7,003,383 shares of common stock and describes an equity line of up to $50 million under a purchase agreement with Lincoln Park Capital Fund.

8-K filing: Surrozen, Inc. repurchased 5,382,499 shares of common stock and warrants to purchase 1,310,496 shares of common stock from Consonance Entities for $2.7 million on December 15, 2022. The repurchased shares will be returned to authorized and unissued status and the warrants will be cancelled. ($5.4M proceeds)

S-3 filing: The company is offering shares of its common stock through an at-the-market offering, with an aggregate offering price of up to $23,000,000, to be sold through Guggenheim Securities, LLC.

10-Q filing | 35.1M shares outstanding

10-Q filing | 35.1M shares outstanding

10-Q filing | 35.1M shares outstanding

POS AM filing: This POS AM filing from 2022-03-29 relates to the issuance of up to 31,612,349 shares of common stock and 4,151,324 warrants.

10-K filing | 35.1M shares outstanding

8-K filing: Surrozen, Inc. entered into a Purchase Agreement with Lincoln Park Capital Fund, LLC, and issued 100,000 shares of Common Stock to Lincoln Park as consideration for their commitment to purchase shares under the agreement, with the potential to sell up to $50,000,000 of newly issued shares.

10-Q filing | 35.0M shares outstanding

S-1/A filing: This S-1/A filing relates to the issuance of up to 7,217,991 shares of common stock upon exercise of warrants and the offer and sale of up to 31,612,349 shares of common stock and 4,151,324 warrants by selling securityholders.

S-1 filing: The filing registers up to 34,277,756 shares of common stock and up to 4,151,324 warrants to purchase common stock for issuance by the company and for sale by selling securityholders.

10-Q filing | 9.6M shares outstanding

10-Q filing | 9.6M shares outstanding

10-K filing | 6.6M shares outstanding

8-K filing: Consonance-HFW Acquisition Corp. consummated an initial public offering of 8,000,000 units at $10.00 per Unit and a private placement with Consonance Life Sciences of 410,000 private placement units at $10.00 per Unit. ($84.1M proceeds)

8-K filing: Consonance-HFW Acquisition Corp. consummated its initial public offering of 8,000,000 units and a private placement with Consonance Life Sciences of 410,000 units. ($84.1M proceeds)

S-1/A filing: Consonance-HFW Acquisition Corp. is offering 8,000,000 units at $10.00 per unit in an initial public offering.

S-1/A filing: Consonance-HFW Acquisition Corp. is offering 10,000,000 units at $10.00 per unit in an initial public offering.

S-1/A filing: This S-1/A filing includes information about other expenses of issuance and distribution, indemnification of directors and officers, recent sales of unregistered securities, and exhibits.

S-1/A filing: Consonance-HFW Acquisition Corp. is conducting an initial public offering of units, each consisting of one Class A ordinary share and one-third of one redeemable warrant, with an offering price of $10.00 per unit, and plans a private placement of Class A ordinary shares to the sponsor concurrent with the business combination.

S-1/A filing: This S-1/A filing describes a proposed public offering, including founder shares, private placement units, and public shares. It defines key terms related to the business combination and the offering.

S-1 filing: Consonance-HFW Acquisition Corp. is conducting an initial public offering of units, with each unit consisting of one Class A ordinary share and one-third of one redeemable warrant, at a price of $10.00 per unit, for a total offering of $100,000,000.